Veronomics

Veronomics is a company developing a series of VeroTests in order to match drug susceptibilities to specific cancers. Its approach combines expertise in genomic gene essentiality screens with drug-identification bioinformatics programs, optimized by proprietary prediction programs and drug sensitivity validation assays.